SYNNF yields 434.78% · MRK yields 2.76%● Live data
📍 SYNNF pulled ahead of the other in Year 1
Combined, SYNNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYNNF + MRK for your $10,000?
Symphony International Holdings Limited is a private equity and venture capital firm specializing in investments in early stage, management buy-outs, emerging growth, management buy-ins, restructurings, special situations, and the provision of growth capital for later-stage development and expansion. It also invests in real estate development. The firm typically invests in innovative and high-growth consumer businesses, new economy, primarily in the education, hospitality, lifestyle logistics, new economy, healthcare, healthcare related services, luxury branded real estate, hospitality and lifestyle sectors. It prefers to make long-term direct investments in the Asia Pacific region with a focus on Australia, India, Indonesia, Malaysia, Singapore, Taiwan, Thailand, Vietnam and Sri Lanka. The firm seeks to achieve control and majority positions in partnership with the management of the acquired business. It seeks to be the lead or sole investor. Symphony International Holdings Limited was founded in 2004 and is based in British Virgin Islands.
Full SYNNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.